Lumend
Redwood City
About Lumend
LuMend Inc. designs, develops, manufactures and markets medical devices intended to enable physicians to safely, predictably and cost effectively cross Chronic Total Occlusions (CTO) in the coronary vasculature, allowing subsequent conventional guide wire placement across target stenotic lesions. The company was founded in 1996 by two pioneering interventional cardiologists, John Simpson, PhD, MD, and Matthew Selmon, MD.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $23.2M
- Funding stage: M&A
- Last round: Series D (Jan 2003)
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical
Canonical: https://fsome.com/organization/lumend-2731144 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.